Faeth Therapeutics (FTH) Other Non Operating Income (2020 - 2026)
Faeth Therapeutics' (FTH) quarterly Other Non Operating Income came in at -$1000.0 in Q1 2026, down 105.56% YoY from $18000.0 in Q1 2025, and little changed on a QoQ basis from -$1000.0 in Q4 2025.
Faeth Therapeutics (FTH) Other Non Operating Income (2020 - 2026) Analysis & Trends
Faeth Therapeutics (FTH) has 7 years of Other Non Operating Income data on file, last reported at -$1000.0 in Q1 2026.
- Quarterly Other Non Operating Income fell 105.56% year-over-year to -$1000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3000.0 (down 117.65% YoY) and the FY2025 annual result came in at -$4000.0, down 33.33% from the prior year.
- Other Non Operating Income held at -$1000.0 in Q1 2026, from -$1000.0 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $68000.0 in Q2 2023 to a low of -$225000.0 in Q3 2023.
- A 5-year average of -$12846.2 and a median of -$1000.0 in 2024 frame the typical range for Other Non Operating Income.
- Annual changes were most pronounced in 2023 — Other Non Operating Income plunged 6800.0% — and 2025, when it jumped 1000.0%.
- Tracing FTH's Other Non Operating Income over 5 years: stood at $1000.0 in 2022, then sank by 6800.0% to -$67000.0 in 2023, then soared by 98.51% to -$1000.0 in 2024, then changed by 0.0% to -$1000.0 in 2025, then changed by 0.0% to -$1000.0 in 2026.
- The last three Other Non Operating Income figures came in at -$1000.0 (Q1 2026), -$1000.0 (Q4 2025), and -$1000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Faeth Therapeutics | 179.31 Mn | 179.31 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 120,000.00 |
| Mar 31, 2026 | -1,000.00 |
| Dec 31, 2025 | -1,000.00 |
| Jun 30, 2025 | -1,000.00 |
| Mar 31, 2025 | 18,000.00 |
| Dec 31, 2024 | -1,000.00 |
| Mar 31, 2024 | -2,000.00 |
| Dec 31, 2023 | -67,000.00 |
| Sep 30, 2023 | -225,000.00 |
| Jun 30, 2023 | 68,000.00 |
| Mar 31, 2023 | 9,000.00 |
| Dec 31, 2022 | 1,000.00 |
| Sep 30, 2022 | 20,000.00 |
| Mar 31, 2022 | 15,000.00 |
| Sep 30, 2021 | 567,000.00 |
| Sep 30, 2020 | -950,000.00 |
| Jun 30, 2020 | 950,000.00 |
| Mar 31, 2020 | 45,000.00 |